Page last updated: 2024-11-04

gatifloxacin and Acute Kidney Injury

gatifloxacin has been researched along with Acute Kidney Injury in 1 studies

Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.

Acute Kidney Injury: Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions.

Research Excerpts

ExcerptRelevanceReference
"Our goal was to report a new case of gatifloxacin-related hyperglycemia in a nondiabetic patient with acute renal dysfunction."7.73Hyperglycemia and gatifloxacin: a case report and summary of current literature. ( Beste, LA; Mersfelder, TL, 2005)
"Our goal was to report a new case of gatifloxacin-related hyperglycemia in a nondiabetic patient with acute renal dysfunction."3.73Hyperglycemia and gatifloxacin: a case report and summary of current literature. ( Beste, LA; Mersfelder, TL, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beste, LA1
Mersfelder, TL1

Other Studies

1 other study available for gatifloxacin and Acute Kidney Injury

ArticleYear
Hyperglycemia and gatifloxacin: a case report and summary of current literature.
    The American journal of geriatric pharmacotherapy, 2005, Volume: 3, Issue:4

    Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Blood Glucose; Coronary Artery Bypass; Fluoroquino

2005